Merck & Co. Inc. buy Guggenheim
Start price
12.02.25
/
50%
€83.40
Target price
12.02.26
€110.77
Performance (%)
15.00%
Price
21.01.26
€95.10
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 15.00%. Dividends of €0.81 are taken into consideration when calculating the performance. This prediction currently runs until 12.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | -0.314% | -0.314% |
| iShares Core DAX® | -1.933% | 2.239% |
| iShares Nasdaq 100 | -0.972% | 0.226% |
| iShares Nikkei 225® | -2.056% | 5.685% |
| iShares S&P 500 | -1.185% | 0.867% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
38.43%
21.01.26
21.01.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24